Financials JW Shinyak Corporation

Equities

A067290

KR7067290007

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 13/05/2024 BST 5-day change 1st Jan Change
1,820 KRW -0.05% Intraday chart for JW Shinyak Corporation -0.66% -26.61%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 278,785 201,714 261,315 185,849 175,309 125,738
Enterprise Value (EV) 1 326,267 212,975 279,717 199,670 185,923 134,782
P/E ratio -36.8 x 140 x -40.5 x 212 x 127 x -3.36 x
Yield 0.89% 1.24% 0.95% - - -
Capitalization / Revenue 3.04 x 1.97 x 2.52 x 1.84 x 1.71 x 1.21 x
EV / Revenue 3.56 x 2.08 x 2.69 x 1.98 x 1.81 x 1.29 x
EV / EBITDA 111 x 55.2 x 102 x 28.4 x 25.2 x 16.2 x
EV / FCF 39.9 x 71 x 82.8 x 26.4 x 28.1 x 27 x
FCF Yield 2.51% 1.41% 1.21% 3.79% 3.56% 3.7%
Price to Book 8.32 x 3.05 x 4.64 x 3.35 x 3.13 x 7.5 x
Nbr of stocks (in thousands) 50,502 50,502 50,502 50,717 50,709 50,701
Reference price 2 5,520 3,994 5,174 3,664 3,457 2,480
Announcement Date 21/03/19 25/03/20 18/03/21 21/03/22 21/03/23 18/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 91,776 102,531 103,803 100,966 102,710 104,235
EBITDA 1 2,943 3,859 2,740 7,041 7,366 8,296
EBIT 1 577.3 1,146 -553.6 3,426 4,287 5,628
Operating Margin 0.63% 1.12% -0.53% 3.39% 4.17% 5.4%
Earnings before Tax (EBT) 1 -4,735 2,618 -6,407 2,572 3,025 -35,597
Net income 1 -7,509 1,442 -6,446 883.8 1,400 -37,357
Net margin -8.18% 1.41% -6.21% 0.88% 1.36% -35.84%
EPS 2 -149.9 28.55 -127.6 17.28 27.21 -737.1
Free Cash Flow 1 8,182 3,001 3,376 7,565 6,612 4,991
FCF margin 8.91% 2.93% 3.25% 7.49% 6.44% 4.79%
FCF Conversion (EBITDA) 278% 77.76% 123.21% 107.43% 89.77% 60.17%
FCF Conversion (Net income) - 208.1% - 855.95% 472.31% -
Dividend per Share 2 49.36 49.36 49.36 - - -
Announcement Date 21/03/19 25/03/20 18/03/21 21/03/22 21/03/23 18/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 47,481 11,261 18,402 13,821 10,613 9,044
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 16.13 x 2.918 x 6.715 x 1.963 x 1.441 x 1.09 x
Free Cash Flow 1 8,182 3,001 3,376 7,565 6,612 4,991
ROE (net income / shareholders' equity) -21.5% 2.91% -10.6% 1.5% 2.49% -104%
ROA (Net income/ Total Assets) 0.31% 0.58% -0.3% 2.27% 2.88% 4.4%
Assets 1 -2,419,815 247,757 2,172,443 38,866 48,615 -848,163
Book Value Per Share 2 663.0 1,310 1,115 1,093 1,104 331.0
Cash Flow per Share 2 28.80 586.0 62.10 19.90 57.10 375.0
Capex 1 1,064 843 1,161 894 1,440 1,044
Capex / Sales 1.16% 0.82% 1.12% 0.89% 1.4% 1%
Announcement Date 21/03/19 25/03/20 18/03/21 21/03/22 21/03/23 18/03/24
1KRW in Million2KRW
Estimates
  1. Stock Market
  2. Equities
  3. A067290 Stock
  4. Financials JW Shinyak Corporation